Status: Not yet recruiting
Post-Market Clinical Follow-Up of S.M.A.R.T. Family of Stents in Treating Iliac and Femoropopliteal Artery Disease
The purpose of this study is to evaluate long-term safety and performance per the intended use of the S.M.A.R.T.™ Nitinol Stent System (SMART 120/150), S.M.A.R.T.™ CONTROL™ Nitinol Stent System (SMART CONTROL) and S.M.A.R.T.™ Flex Vascular Stent System (SMART Flex) in the treatment of iliac and femoropopliteal artery disease.
Participants needed: 240
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Cordis US Corp.Updated: Jan 14, 2026Locations: 1
Eligibility criteria
Subjects treated with SMART 120/150, SMART CONTROL or SMART Flex according to th... [+1]
Women who were pregnant or lactating at the time of the procedure. [+1]